Cite

HARVARD Citation

    Suruki, R. et al. (2022). Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study. Rheumatology. pp. e236-e237. [Online]. 
  
Back to record